CD28 and CTLA-4 costimulatory molecules expression on T lymphocytes and NK cells in nonallergic bronchial asthma;Ekspresja cza̧steczek kostymuluja̧cych CD28 i CTLA-4 na limfocytach T i komórkach NK u chorych na niealergiczna̧ astmȩ oskrzelowa̧

Polski Merkuriusz Lekarski

Volumn 20, Issue 116, 2006, Pages 139-144

  Rutkowski, Ryszard ^a   Stasiak Barmuta, Anna ^a   Moniuszko, Tadeusz ^a   Rutkowska Rogacz, Danuta ^a   Woińska, Marzanna ^a   Rutkowski, Krzysztof ^a   Sidorczuk, Malłgorzata ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Costimulatory molecules CD28; CTLA 4 expression; NK cells; Nonatopic bronchial asthma; T lymphocytes

Indexed keywords

CD16 ANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 15; LIPOPOLYSACCHARIDE; ANTIINFLAMMATORY AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; DRUG DERIVATIVE; LEUKOCYTE ANTIGEN; PREDNISONE; SALBUTAMOL; SALMETEROL;

ADULT; ARTICLE; ASTHMA; CELL SUBPOPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; NATURAL KILLER CELL; PATHOGENESIS; RECURRENT INFECTION; RESPIRATORY TRACT INFECTION; T LYMPHOCYTE ACTIVATION; IMMUNOLOGY; MIDDLE AGED; T LYMPHOCYTE;

ADRENERGIC BETA-AGONISTS; ADULT; ALBUTEROL; ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, DIFFERENTIATION; ASTHMA; FEMALE; HUMANS; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; PREDNISONE; T-LYMPHOCYTES;

EID: 33644973308     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Anderson M.S.: Autoimmune endocrine disease. Curr. Opin. Immunol., 2002, 14, 760-764.
2. Andersson J., Ahmed R.: Immunity to infection. Curr. Opin. Immunol., 2002, 14, 409-412.
3. Chambers A.A., Allison J.P.: Co-stimulation in T cell responses. Curr. Opin. Immunol., 1997, 9, 396-404.
4. Chambers C.A.: The expanding world of co-stimulation, the two-signal model revisited. Trends Immunol., 2001, 22, 217-223.
5. + regulatory T cells in autoimmunity and allergy. Curr. Opin. Immunol., 2002, 14, 771-778.
6. Deurloo D.T., van Esch B.C., Hofstra C.L. i wsp.: CTLA4-IgG reverses asthma manifestations in a mild but not in a more "severe" ongoing murine model. Am. J. Respir. Cell Mol. Biol., 2001, 25, 6, 751-60.
7. Fecteau S., Bassadonna G.P., Freitas A. i wsp.: CTLA-4 up-regulation plays a role in tolerance mediated by CD45. Nat. Immunol., 2001, 2, 58-63.
8. Hellings P.W., Vanderberghe P., Kasran A. i wsp.: Blockade of CTLA-4 enhances allergic sensitization and eosinophilic airway inflammation in genetically predisposed mice. Eur. J. Immunol., 2002, 32, 585-94.
9. Hurwitz A.A., Kwon E.D., van Elsas A.: Costimulatory wars, the tumor menace. Curr. Opin. Immunol., 2000, 12, 589-596.
10. Jenkins M.K., Taylor P.S., Norton S.D. i wsp.: CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. J. Immunol., 1991, 147, 2461-2466.
11. June C.H., Bluestone J.A., Nadler L.M. i wsp.: The B7 and CD28 receptor families. Immunol. Today, 1994, 15, 321-331.
12. Krummel M.F., Allison J.P.: CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med., 1996, 183, 2533-2540.
13. Lanier L.L.: Face off - the interplay between activating and inhibitory immune receptors. Curr. Opin. Immunol., 2001, 13, 326-331.
14. Lenschow D.J., Walnus T.L., Blustone J.A.: CD28/B7 system of T cell costimulation. Annu. Rev. Immunol., 1996, 14, 233-258.
15. Linsley P.S., Brady W., Grosmaire L. i wsp.: Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med., 1991, 173, 721-730.
16. Moniuszko T., Rutkowski R., Tatarczuk-Krawiel A. i wsp.: Wpływ monocytów stymulowanych LPS na ekspresjȩ CD69 na limfocytach T u chorych na astmȩ niealergiczna̧. Pol. Merk. Lek., 2002, 12, 181-184.
17. Mueller D.L: T cells, a proliferation of costimulatory molecules. Curr. Biol., 2000, 10, 227-230.
18. Noroski L.M., Shaerer W.T.: Screening for primary immunodeficiencies in the clinical immunology laboratory. Clin. Immunol. Immunopathol., 1998, 86, 237-245.
19. Puck J.M.: Primary Immunodeficiency Diseases. JAMA, 1997, 278, 22, 1835-1841.
20. Rutkowski R., Moniuszko T., Stasiak-Barmuta A. i wsp.: Wpływ inaktywacji cza̧steczek kostymulacyjnych B7.1 (CD80), B7.2 (CD86) na aktywność limfocytów T. Pol. Merk. Lek., 2002, 12, 185-189.
21. Schwartz R.H.: Costimulation of T lymphocytes, the role of CD28, CTLA-4, and B7/BB1 in interlekin-2 production and immunotherapy. Cell, 1992, 71, 1065-1068.
22. Stasiak-Barmuta A., Puchnarewicz A., Hofman J.: Hormon grasic cielȩcych TFX w terapii astmy oskrzelowej niealergicznej powikłanej zapaleniem płuc i opłucnej. Pol. Merk. Lek., 1998, 4, 23, 275-276.
23. Stephan J.L., Vlekova V., Fischer A.: Severe combined immunodeficiency: A retro spective single-center study of clinical presentation and outcome in 117 patiants. J. Pediatr., 1993, 123, 564-572.
24. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med., 2000, 192, 303-310.
25. Tivol E.A., Schweitzer A.N., Sharpe A.M.: Costimulation and autoimmunity. Curr. Opin. Immunol., 1996, 8, 822-830.
26. Walunas T.L., Lenschow D.J., Bakker C.Y. i wsp.: CTLA-4 can function as a negative regulator of T cell activation. Immunity, 1994, 1, 405-413.
27. Watts T.H., DeBenedette M.A.: T cell co-stimulatory molecules other than CD28. Curr. Opin. Immunol., 1999, 11, 286-293.
28. Weiss A., Litman D.R.: Signal transduction by lymphocytes antigen receptor. Cell, 1994, 76, 263-274.
29. Yoshinaga S.K., Whoriskey J.S., Khare S.D. i wsp.: T-cell co-stimulation through B7RP-1 and ICOS. Nature, 1999, 402, 827-832.